RT Generic
T1 Editorial: Antivirulence Drugs Against Bacterial Infections.
A1 Imperi, Francesco
A1 Chen, Wangxue
A1 Smani, Younes
K1 antivirulence
K1 bacteria
K1 drug
K1 infection
K1 treatment
AB Antimicrobial resistance poses a well-recognized public health threat worldwide due to the global dissemination of bacteria resistant to multiple antibiotic classes and the development of severe infections such as bacteremia , pneumonia , urinary tract , and intraabdominal infections .
PB Frontiers Research Foundation
SN 1664-302X
YR 2021
FD 2021-05-25
LK http://hdl.handle.net/10668/17988
UL http://hdl.handle.net/10668/17988
LA en
NO Imperi F, Chen W, Smani Y. Editorial: Antivirulence Drugs Against Bacterial Infections. Front Microbiol. 2021 May 25;12:690672.
DS RISalud
RD Apr 5, 2025